PATENT CLAIM ANALYSIS

Application Number: 16391537
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "311000"]

Abstract:
A cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereof, wherein the structural formula of the compound is as follows: An application of the compound or its pharmaceutically acceptable salts, hydrates, solvates, or prodrugs in preparing a drug for treating and/or preventing and/or delaying and/or providing adjuvant therapy for asthma and/or allergic rhinitis and asthma syndromes is provided. A drug composition includes the cyclopropyl unsaturated quinoline compound or the pharmaceutically acceptable salts, hydrates, solvates, or prodrugs thereof. The compound series has favorable foreground in preparing drugs for treating and/or preventing and/or delaying and/or providing adjuvant therapy for asthma and/or allergic rhinitis and asthma syndromes.

Claim (Index 5):
A drug composition according to  claim 4 , further comprising a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 100.0
- Lexical Diversity: 2.03448
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15505040', '12644378', '13885986', '12089706', '12131828']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.750379372289836
- 35 USC 102 Novelty (BERT): 0.5587091752243536
- Combined Prediction Score: 0.7312123525832878
- Mean Citation Score: 244.377818
- Max Citation Score: 453.89694
- Similarity Product: 320.29482493192074

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test